Alcon Stock

Alcon Stocks

The number of shares of Alcon (ALC.SW) as of Mar 19, 2026.

Stocks

0

Last updated:

In 2026, Alcon had 0 outstanding stocks, a % change from the 0 stocks in the previous year.

The Alcon Stocks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

NUMBER OF STOCKS (M USD)
Date
NUMBER OF STOCKS (M USD)
Jan 1, 2016
488.7 base
Jan 1, 2017
488.7 base
Jan 1, 2018
488.7 base
Jan 1, 2019
488.2 base
Jan 1, 2020
489 base
Jan 1, 2021
493.4 base
Jan 1, 2022
494.4 base
Jan 1, 2023
496.5 base
Jan 1, 2024
497.5 base
Invalid Date
497.5 base
Invalid Date
497.5 base
Invalid Date
497.5 base
Invalid Date
497.5 base
Invalid Date
497.5 base
Invalid Date
497.5 base
YEARNUMBER OF STOCKS (M USD)
2031 est 497.5
2030 est 497.5
2029 est 497.5
2028 est 497.5
2027 est 497.5
2026 est 497.5
2025 est 497.5
2024 497.5
2023 496.5
2022 494.4
2021 493.4
2020 489
2019 488.2
2018 488.7
2017 488.7
2016 488.7
Access this data via the Eulerpool API
Get Free API Key

Alcon Shares Outstanding

Alcon shares outstanding

The number of shares was Alcon in 2025 — This indicates how many shares 497.5 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2016
488.7 M base_Shares
Jan 1, 2017
488.7 M base_Shares
Jan 1, 2018
488.7 M base_Shares
Jan 1, 2019
488.2 M base_Shares
Jan 1, 2020
489 M base_Shares
Jan 1, 2021
493.4 M base_Shares
Jan 1, 2022
494.4 M base_Shares
Jan 1, 2023
496.5 M base_Shares
Jan 1, 2024
497.5 M base_Shares
Invalid Date
497.5 M base_Shares
Invalid Date
497.5 M base_Shares
Invalid Date
497.5 M base_Shares
Invalid Date
497.5 M base_Shares
Invalid Date
497.5 M base_Shares
Invalid Date
497.5 M base_Shares

Alcon Stock analysis

What does Alcon do? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon is one of the most popular companies on Eulerpool.

Stocks Details

Evaluating Alcon's Shares Outstanding

Alcon's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Alcon’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Alcon’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Alcon’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Alcon stock

On Eulerpool you can find the complete historical development of The number of shares Alcon since 2006 – with annual values, charts, and detailed analysis.

Access this data via the Eulerpool API
Get Free API Key

Other — Alcon

StocksSupply ChainNet Debt per ShareAssets per Share
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — Alcon